Slowing the degenerative process, long lasting effect of hyperbaric oxygen therapy in retinitis pigmentosa

  • Enzo Maria Vingolo
  • Monica Rocco
  • PierLuigi Grenga
  • Serena Salvatore
  • Paolo Pelaia
Retinal Disorders



Retinitis pigmentosa (RP) therapy is still an unsolved challenge. Recent reports have underlined that hyperbaric oxygen (HBO) therapy could play a role in slowing the retinal degenerative process. The aim of this study was to assess the efficacy of HBO therapy on visual function in RP patients.


We performed a single-center, comparative, longitudinal case-controlled randomized clinical trial, which lasted 10 years. We randomly divided RP patients into two groups. Group 1, the control group, consisted of 44 RP patients (21 males and 23 females; mean age 35.5) who took Vitamin A. Group 2, with 44 RP patients (21 males and 23 females; mean age 35,02), underwent HBO therapy. No statistically significant difference was found at the beginning of the study between the two groups. We compared the results concerning visual acuity, Goldmann perimetry, static perimetry Humphrey field analyzer (HFA), and electroretinogram (ERG) obtained in the two groups at 5 and 10 years follow-up. Statistical analysis was performed with Kaplan-Meier life-table with the evaluation of log-rank coefficient.


At 5 year follow-up, 87.5% of group 2 patients preserved 80% of the initial visual acuity, while the same result was achieved in only 70.4% of group 1 patients (X2 = 8.2; p < 0.01); at 10 year follow-up, 63.33% of group 2 patients preserved 80% of the initial visual acuity, while the same percentage of residual visual acuity was maintained in 40% of group 1 patients (X2 = 3.22; p = 0.05). At 10 year follow-up, Goldmann perimetry (target I4e) did not change in 31.6% of group 2 and in 10.5% of group 1; evaluation of mean defect (MD) with static perimetry HFA showed that 53% of HBO patients had 80% of residual mean sensitivity compared to 23.5% of the control group patients (X2 = 4.72; p = 0.035). ERG b-wave mean values at the end of the protocol were significantly higher in the HBO treated group (X2 = 4.53; p = 0.013).


Our study underlines that HBO therapy can be a safe alternative approach to RP patients, contributing to the stabilization of their visual function concerning visual acuity, visual field, and ERG responses while waiting for a definite cure.


Retinitis pigmentosa Hyperbaric oxygen therapy Retina 


  1. 1.
    Marmor MF, Aguirre G, Arden G, Berson EL (1983) Retinitis pigmentosa symposium on terminology and methods of examination. Ophthalmology 90:126–131Google Scholar
  2. 2.
    Berson EL (1993) Retinitis pigmentosa. The Friedenwald lecture. Invest Ophthahlmol Vis Sci 34:1659–1676Google Scholar
  3. 3.
    Berson EL, Rosner B, Sandberg MA et al (1993) A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol 111:761–772PubMedGoogle Scholar
  4. 4.
    Jacobson SG, Kemp CM, Sung CH, Nathans J (1991) Retinal function and rhodopsin levels in autosomal dominant retinitis pigmentosa with rhodopsin mutations. Am J Ophthalmol 112:256–271PubMedGoogle Scholar
  5. 5.
    Berson EL, Sandberg MA, Rosner B, Birch DG, Hanson AH (1985) Natural course of retinitis pigmentosa over three year interval. Am J Ophthalmol 99:240–251PubMedGoogle Scholar
  6. 6.
    Weinstein GW, Mannemmee AE, Hyvarinen L (1971) On the pathogenesis of retinitis pigmentosa. Ophtalmologica 65:82–97Google Scholar
  7. 7.
    Vingolo EM, Pelaia P, Forte R, Rocco M, Giusti C, Rispoli E (1999) Does hyperbaric oxygen (HBO) delivery rescue retinal photoreceptors in retinitis pigmentosa? Doc Opht 97:33–39CrossRefGoogle Scholar
  8. 8.
    Pannarale L, Forte R, Amodeo S, Pierazzi MC (1993) Retinitis pigmentosa clinical and epidemiological aspects. Boll Ocul 783–788Google Scholar
  9. 9.
    Pannarale MR (1992) Clinical introduction to retinitis pigmentosa. Proceedings of the Workshop on RP, Rome, Italy, March 1991Google Scholar
  10. 10.
    Vingolo EM, Giusti C, Forte R, Onori P (1996) Vitreal alterations in retinitis pigmentosa: biomicroscopic appearance and statistical evaluation. Ophthalmologica 210:104–107PubMedGoogle Scholar
  11. 11.
    Rispoli E, Iannaccone A, Vingolo EM (1994) Low-noise electroretinogram recording techniques in retinitis pigmentosa. Doc Ophth 88:27–37CrossRefGoogle Scholar
  12. 12.
    Marmor MF, Arden GB, Nilsson SE, Zrenner E (1989) Standard for clinical electroretinography. Arch Ophthalmol 107:816–819Google Scholar
  13. 13.
    Shimazaki H, Oakley B (1986) Decline of electrogenic Na/K pump activity in rod photoreceptors during maintained illumination. J Gentile Physiol 87:633CrossRefGoogle Scholar
  14. 14.
    Steinberg RH (1987) Monitoring communication between photoreceptor and pigment epithelial cells: effects of mild systemic hypoxia. Invest Ophthalmol Vis Sci 28:1888–1904PubMedGoogle Scholar
  15. 15.
    Stone J, Maslim J, Valter K, Mervin K (1996) The influence of oxygen levels on the death and survival of photoreceptors. In: Anderson RE (ed) Retinal degeneration in degenerative diseases of the retina. Plenum Press, New York, USA, pp 371–377Google Scholar
  16. 16.
    Rispoli E, Verde AM, De Marco G, Vingolo EM, Mucci A (1988) Modificazioni elettrofisiologiche oculari dell’insufficienza respiratoria cronica. Clin Ocul e Patol Ocul IX:393–397Google Scholar
  17. 17.
    Bunker CH, Berson EL, Bramley WC, Hoyes RP, Roderick TH (1984) Prevalence of retinitis pigmentosa in Maine. Am J Ophthalmol 97:357PubMedGoogle Scholar
  18. 18.
    Heckenlively JR, Solish AM, Chant SM, Meyers-Elliot RM (1985) Autoimmunity in hereditary retinal degeneration. II clinical studies: autoretinal antibodies and fluorescein angiogram findings. Br J Ophthalmol 69:758–764PubMedCrossRefGoogle Scholar
  19. 19.
    Stryer L (1991) Visual excitation and recovery. J Biolog Chem 266:10711–10714Google Scholar
  20. 20.
    Langham ME, Kramer T (1990) Decreased choroidal blood flow associated with retinitis pigmentosa. Eye 4:374–381PubMedGoogle Scholar
  21. 21.
    Kiryu J, Ogura Y (1996) Hyperbaric oxygen treatment for macular edema in retinal vein occlusion: relation to severity of retinal leakage. Ophthalmologica 210:168–170PubMedCrossRefGoogle Scholar
  22. 22.
    Li HK, Dejean BJ, Tang RA (1996) Reversal of visual loss with hyperbaric oxygen treatment in patient with Susac syndrome. Ophthalmology 103:2091–2098PubMedGoogle Scholar
  23. 23.
    Bojic L, Ivanisevic M, Gosovic G (2002) Hyperbaric oxygen therapy in two patients with non artheritic anterior optic neuropathy who did not respond to prednisone. Undersea Hyperb Med 29:86–92PubMedGoogle Scholar
  24. 24.
    Verin PH, Compte P, Poisot D (1986) Retinite pigmentaire et oxygenotherapie hyperbare. Bull Soc Opht Fran LXXXVI:1071–1074Google Scholar
  25. 25.
    Skogstad M, Bast Pettersen R et al (1994) Treatment with hyperbaric oxygen. Illustrated by the treatment of a patient with retinitis pigmentosa. Tidssk Nor Laegeforen 114:2480–2483Google Scholar
  26. 26.
    Chachia N, Combes AM, Romdane K (1987) Maculopathy in typical retinitis pigmentosa apropos of 33 cases. J Fr Ophtalmol 10:381–386PubMedGoogle Scholar
  27. 27.
    Hori S (1982) Study on hyperbaric oxygen. Induced convulsion with particular reference to GABA in synaptosomes. J Biochem 9:443–452Google Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Enzo Maria Vingolo
    • 1
  • Monica Rocco
    • 2
  • PierLuigi Grenga
    • 1
  • Serena Salvatore
    • 1
    • 3
  • Paolo Pelaia
    • 2
  1. 1.Inherited Degenerative Retinal Diseases Unit, Department of OphthalmologyPoliclinico Umberto I, University of Rome “La Sapienza”RomeItaly
  2. 2.Department of AnesthesiologyPoliclinico Umberto I, University of Rome “La Sapienza”RomeItaly
  3. 3.RomeItaly

Personalised recommendations